Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/1996
07/03/1996EP0719141A1 Novel use of dexmedetomidine
07/03/1996EP0719140A1 Use of thiazolidinediones to prevent or delay onset of niddm
07/03/1996EP0719138A1 Iontophoretic delivery of an antimigraine drug
07/03/1996CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors
07/03/1996CN1125938A Bicyclic amide derivatives and their use as muscle relaxants
07/03/1996CN1125725A First-kind "Haikelin" alkali derivant and its usage
07/03/1996CN1125717A Cyclohexadiene derivatives
07/03/1996CN1032209C Process for preparing 2-piperidino-1-alkanol derivatives as antiischemic agents
07/03/1996CN1032207C Process for preparing imidazopyrazole derivatives, witch use as analgesics and anti-inflammatory agents
07/02/1996US5532415 Monoamine oxidase inhibitors; parkinson's disease, nervous system disorders; cognition activators
07/02/1996US5532375 Process for preparing 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oximes
07/02/1996US5532372 With a 1,2-benzisothiazole ring attached at its 3-position to a piperazine nitrogen; antipsychotics; includes lurasidone in claim 17
07/02/1996US5532368 Xanthine derivatives with adenosine-antagonistic activity
07/02/1996US5532305 Hyaluronic acid and cationic polyacrylic acid copolymer for time release agents
07/02/1996US5532274 Levodopa, carbidopa, vinyl acetate-vinyl alcohol copolymer
07/02/1996US5532266 Treatment of hypoxia, antiedemic agents or antiinflammatory agents
07/02/1996US5532249 Alzheimers
07/02/1996US5532243 Antipsychotic nitrogen-containing bicyclic compounds
07/02/1996US5532242 Central nervous system cognition activators, anxiety and antidepressants
07/02/1996US5532241 Cns activity
07/02/1996US5532237 Intraocular for treatment of glaucoma
07/02/1996US5532236 [1,2,4]triazolo[4,3-a]quinoxaline compounds
07/02/1996US5532235 Tricyclic benzazepine vasopressin antagonists
07/02/1996US5532233 Platelet activating factor antagonist
07/02/1996US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates
06/1996
06/30/1996CA2166234A1 3-phenylisoquinol-1(2h)-one derivatives, their preparation and their therapeutic application
06/30/1996CA2166233A1 8-oxo-5,8-dihydro-6h-dibenzo¬a,g|quinolizine-13-propanoic acid derivatives, their preparation and their therapeutic application
06/27/1996WO1996019499A2 Improved cyclic crf antagonists
06/27/1996WO1996019477A1 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists
06/27/1996WO1996019469A1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
06/27/1996WO1996019463A1 Heteroaromatic oxazole compounds and use thereof
06/27/1996WO1996019462A1 Oxazole derivatives and use thereof
06/27/1996WO1996019455A1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
06/27/1996WO1996019451A1 Substituted azetidin-2-ones for treatment of atherosclerosis
06/27/1996CA2341921A1 Amide compounds intermediates
06/27/1996CA2208530A1 Substituted azetidin-2-ones for treatment of atherosclerosis
06/27/1996CA2208316A1 Oxazole derivatives and use thereof
06/27/1996CA2208244A1 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists
06/27/1996CA2208011A1 Aryl-and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
06/27/1996CA2206978A1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
06/27/1996CA2206059A1 Improved cyclic crf antagonists
06/27/1996CA2183645A1 Heterocyclic aromatic oxazole compounds and use thereof
06/26/1996EP0718299A1 Tricyclic oxime ethers process for their preparation and pharmaceutical compositions containing them
06/26/1996EP0718297A1 Pyrazine derivatives as muscarinic receptor agonists
06/26/1996EP0718294A1 2-Amino-1,3-thiazepines and their use as inhibitors of the nitrogene oxide synthase
06/26/1996EP0718286A1 3-Alkoxybenzylpiperidine derivatives as melatonergic agents
06/26/1996EP0717998A1 Use of substance P antagonist for the treatment of pruritis, eye or eyelid pain or disesthesies
06/26/1996EP0717995A2 Cell degeneration suppressing and organ toxicity reducing agent
06/26/1996EP0717991A1 Neurotropic agent and process for producing it
06/26/1996EP0717739A1 Bicyclic aromatic compounds as therapeutic agents
06/26/1996EP0717733A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
06/26/1996EP0717635A1 Methods for regulating gastrointestinal motility
06/26/1996EP0717633A1 Growth differentiation factor-7
06/26/1996EP0717624A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
06/26/1996EP0717623A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
06/26/1996EP0717620A1 Substituted 2-aminotetralins
06/26/1996EP0717592A1 Method and composition for the treatment of apathy-amotivation syndrome
06/26/1996EP0697859A4 Stable, ingestable and absorbable nadh and nadph therapeutic compositions
06/26/1996EP0696201A4 Supplemented and unsupplemented tissue sealants, methods of their production and use
06/26/1996EP0607274B1 3-(N-ISOPROPYL-N-n-PROPYLAMINO)-5-(N-ISOPROPYL)CARBAMOYLCHROMAN
06/26/1996EP0575361B1 New 1-aryl-4-piperazinyl-cyclohexanecarboxylic acid nitriles, their production and their use
06/26/1996CN1125446A |1,2,4¨triazolo|4,3-a¨quinoxaline compounds, their preparation and use
06/26/1996CN1125445A Novel chemical compounds having PDE-IV inhibition activity
06/26/1996CN1125442A Imidazole lipoxygenase inhibitors
06/26/1996CN1125221A 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effect
06/25/1996US5530138 Compounds and use thereof
06/25/1996US5530134 Synthesis of anabaseine, salts and derivatives thereof
06/25/1996US5530125 Reacting arylacetamide with strong base in inert aprotic solvent, then with specified reactant in presence of transition metal catalyst to add alpha-substituent,reducing to amine
06/25/1996US5530109 DNA encoding glial mitogenic factors
06/25/1996US5530101 Humanized immunoglobulins
06/25/1996US5530014 Cyclohexadiene derivatives
06/25/1996US5530012 3-alkoxybenzylpiperidine derivatives as melatonergic agents
06/25/1996US5530010 Methods of inhibiting demyelinating and dysmyelinating diseases
06/25/1996US5530009 Treating asthma
06/25/1996US5530002 Anidepressant, anxiolytic agent, hypotensive and treats disorders linked to alcoholism, sleep, phobias, obsessive compulsive behavior and migraine
06/25/1996US5529996 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
06/25/1996US5529995 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ACE
06/25/1996US5529898 Methods of detecting disorders of the central nervous system by detecting autoantibodies which specifically bind ionotropic glutamate receptors
06/25/1996CA1338416C Muscarinic receptor antagonists
06/23/1996CA2165603A1 3-alkoxybenzylpiperidine derivatives as melatonergic agents
06/22/1996CA2165751A1 Quinuclidine and azabicyclo¬2.2.1|heptane pyrazinyl ethers as muscarinic agonists
06/20/1996WO1996018740A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons
06/20/1996WO1996018738A2 PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES
06/20/1996WO1996018650A1 Novel receptor
06/20/1996WO1996018649A1 Improved cyclic crf agonists
06/20/1996WO1996018643A1 Tachykinin antagonists
06/20/1996WO1996018600A1 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor
06/20/1996WO1996018418A1 Improved adenoviral vectors and producer cells
06/20/1996WO1996018407A1 Use of incense in the treatment of alzheimer's disease
06/20/1996WO1996018399A1 Aryl thioxanthines
06/20/1996WO1996018395A1 Use of pramipexole as a neuroprotective agent
06/20/1996WO1996018391A2 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
06/20/1996WO1996004254A3 Benzodiazepine derivatives
06/20/1996DE4444288A1 Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit Use of incense for treating Alzheimer's disease
06/20/1996CA2208224A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons
06/20/1996CA2207921A1 Novel receptor
06/20/1996CA2207581A1 Probin tyrosine kinase (pyk2) its cdna cloning and its uses
06/20/1996CA2207576A1 Improved cyclic crf agonists
06/20/1996CA2207437A1 Use of incense in the treatment of alzheimer's disease
06/20/1996CA2206683A1 Improved adenoviral vectors and producer cells
1 ... 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 ... 1833